Pre 2014 Editorial Advisory Board

Kevin D. Altria GlaxoSmithKline, Ware, United Kingdom

Jared L. Anderson The University of Toledo, Ohio

Daniel W. Armstrong The University of Texas, Arlington, Texas

Michael P. Balogh Waters Corp., Milford, Massachusetts

Brian A. Bidlingmeyer Agilent Technologies, Wilmington, Delaware

Dennis D. Blevins Agilent Technologies, Wilmington, Delaware

Peter Carr Department of Chemistry, University of Minnesota, Minneapolis, Minnesota

Jean-Pierre Chervet Antec Leyden, Zoeterwoude, The Netherlands

John W. Dolan LC Resources, Walnut Creek, California

Michael W. Dong Genentech, San Francisco, California

Roy Eksteen Sigma-Aldrich/Supelco, Bellefonte, Pennsylvania

Anthony F. Fell School of Pharmacy, University of Bradford, Bradford, United Kingdom

Francesco Gasparrini Dipartimento di Studi di Chimica e Tecnologia delle Sostanze Biologicamente Attive, Università "La Sapienza," Rome, Italy

Joseph L. Glajch Momenta Pharmaceuticals, Cambridge, Massachusetts

Richard Hartwick PharmAssist Analytical Laboratory, Inc., South New Berlin, New York

Milton T.W. Hearn Center for Bioprocess Technology, Monash University, Clayton, Victoria, Australia

John V. Hinshaw BPL Global, Ltd., Hillsboro, Oregon

Kiyokatsu Jinno School of Materials Science, Toyohashi University of Technology, Toyohashi, Japan

Ira S. Krull Northeastern University, Boston, Massachusetts

Ronald E. Majors Agilent Technologies, Wilmington, Delaware

R.D. McDowall McDowall Consulting, Bromley, United Kingdom

Michael D. McGinley Phenomenex, Inc., Torrance, California

Victoria A. McGuffin Department of Chemistry, Michigan State University, East Lansing, Michigan

Mary Ellen McNally E.I. du Pont de Nemours & Co., Wilmington, Delaware

Imre Molnár Molnar Research Institute, Berlin, Germany

Glenn I. Ouchi Brego Research, San Jose, California

Colin Poole Department of Chemistry, Wayne State University, Detroit, Michigan

Fred E. Regnier Department of Chemistry, Purdue University, West Lafayette, Indiana

Pat Sandra Research Institute for Chromatography, Kortrijk, Belgium

Peter Schoenmakers Department of Chemical Engineering, University of Amsterdam, Amsterdam, The Netherlands

Kevin Schug University of Texas, Arlington, Texas

Dwight Stoll Gustavus Adolphus College, St. Peter, Minnesota

Michael E. Swartz Ariad Pharmaceuticals, Cambridge, Massachusetts

Thomas Wheat Waters Corporation, Milford, Massachusetts

CONSULTING EDITORS: Jason Anspach, Phenomenex, Inc., Stuart Cram, Thermo Fisher Scientific; David Henderson, Trinity College; Tom Jupille, LC Resources; Sam Margolis, The National Institute of Standards and Technology; Joy R. Miksic, Bioanalytical Solutions LLC; Frank Yang, Micro-Tech Scientific.